Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM2PM5BP4_Moderate
The NM_013335.4(GMPPA):c.1000A>G(p.Thr334Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T334M) has been classified as Likely pathogenic.
GMPPA (HGNC:22923): (GDP-mannose pyrophosphorylase A) This gene is thought to encode a GDP-mannose pyrophosphorylase. This enzyme catalyzes the reaction which converts mannose-1-phosphate and GTP to GDP-mannose which is involved in the production of N-linked oligosaccharides. [provided by RefSeq, Jul 2008]
Loss of catalytic residue at T334 (P = 0.0626);.;Loss of catalytic residue at T334 (P = 0.0626);Loss of catalytic residue at T334 (P = 0.0626);Loss of catalytic residue at T334 (P = 0.0626);Loss of catalytic residue at T334 (P = 0.0626);